These analyses used Tau-specific antibodies and, as far as conventional immunohistochemistry is concerned, required antigen retrieval methods, unless Tau was over-expressed as is the case for Tau transgenic mice that model the Tau pathology in AD and FTD36. This evidence concerns the gene MAPT and Alzheimer disease.